1. Home
  2. ONMD vs LSTA Comparison

ONMD vs LSTA Comparison

Compare ONMD & LSTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ONMD
  • LSTA
  • Stock Information
  • Founded
  • ONMD 2006
  • LSTA 1980
  • Country
  • ONMD United States
  • LSTA United States
  • Employees
  • ONMD N/A
  • LSTA N/A
  • Industry
  • ONMD
  • LSTA Misc Health and Biotechnology Services
  • Sector
  • ONMD
  • LSTA Health Care
  • Exchange
  • ONMD Nasdaq
  • LSTA Nasdaq
  • Market Cap
  • ONMD 32.5M
  • LSTA 31.2M
  • IPO Year
  • ONMD N/A
  • LSTA N/A
  • Fundamental
  • Price
  • ONMD $0.99
  • LSTA $2.64
  • Analyst Decision
  • ONMD
  • LSTA Strong Buy
  • Analyst Count
  • ONMD 0
  • LSTA 1
  • Target Price
  • ONMD N/A
  • LSTA $15.00
  • AVG Volume (30 Days)
  • ONMD 140.2K
  • LSTA 72.4K
  • Earning Date
  • ONMD 12-17-2024
  • LSTA 02-27-2025
  • Dividend Yield
  • ONMD N/A
  • LSTA N/A
  • EPS Growth
  • ONMD N/A
  • LSTA N/A
  • EPS
  • ONMD 0.01
  • LSTA N/A
  • Revenue
  • ONMD $957,651.00
  • LSTA N/A
  • Revenue This Year
  • ONMD N/A
  • LSTA N/A
  • Revenue Next Year
  • ONMD N/A
  • LSTA N/A
  • P/E Ratio
  • ONMD $120.13
  • LSTA N/A
  • Revenue Growth
  • ONMD 1.36
  • LSTA N/A
  • 52 Week Low
  • ONMD $0.46
  • LSTA $2.19
  • 52 Week High
  • ONMD $3.37
  • LSTA $4.20
  • Technical
  • Relative Strength Index (RSI)
  • ONMD 41.12
  • LSTA 42.17
  • Support Level
  • ONMD $0.95
  • LSTA $2.45
  • Resistance Level
  • ONMD $1.06
  • LSTA $2.74
  • Average True Range (ATR)
  • ONMD 0.12
  • LSTA 0.32
  • MACD
  • ONMD -0.03
  • LSTA -0.05
  • Stochastic Oscillator
  • ONMD 7.66
  • LSTA 16.48

About ONMD OneMedNet Corp

OneMedNet Corp is a healthcare software company with solutions focused on digital medical image management, exchange, and sharing. It is a global provider of clinical imaging innovation and curator of regulatory-grade Imaging Real-World Data or iRWDTM. OneMedNet's innovative solutions connect healthcare providers and patients satisfying a crucial need within the Life Sciences field offering direct access to clinical images and the associated contextual patient record.

About LSTA Lisata Therapeutics Inc.

Lisata Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative therapies for the treatment of advanced solid tumors and other major diseases. Its product candidate, LSTA1, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively.

Share on Social Networks: